학술논문
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial
Document Type
Article
Author
Costa, Alberto C S ; Brandão, Ana C; Boada, Richard; Barrionuevo, Veridiana L; Taylor, Hudson G; Roth, Elizabeth; Stasko, Melissa R; Johnson, Mark W; Assir, Fernanda F; Roberto, Maria P; Salmona, Patrícia; Abreu-Silveira, Guilherme; Bederman, Ilya; Prendergast, Erin; Hüls, Anke; Abrishamcar, Sarina; Mustacchi, Zan; Scheidemantel, Thomas; Roizen, Nancy J; Ruedrich, Stephen
Source
In The Lancet Neurology January 2022 21(1):31-41
Subject
Language
ISSN
1474-4422